Francisca Wollerton

Title: The Innovative Contributions of Francisca Wollerton

Introduction

Francisca Wollerton is a notable inventor based in Cambridge, GB. She has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules. With a total of 5 patents to her name, Wollerton's work has the potential to impact the treatment of various diseases, including cancer.

Latest Patents

Wollerton's latest patents include groundbreaking innovations such as antibody molecules that bind PD-L1 and CD137. This application relates to antibody molecules capable of inducing agonism of CD137, which can be crucial in treating diseases like cancer. Another significant patent involves anti-mesothelin antibodies, which bind to mesothelin (MSLN) and are applicable in the treatment and diagnosis of cancer-related disorders.

Career Highlights

Throughout her career, Wollerton has worked with prominent companies in the biotechnology sector, including Invox Pharma Limited and F-star Therapeutics, Inc. Her expertise and innovative approach have positioned her as a key player in the development of therapeutic antibodies.

Collaborations

Wollerton has collaborated with talented individuals in her field, including Jose Munoz-Olaya and Mihriban Tuna. These collaborations have further enhanced her research and development efforts, leading to advancements in antibody technology.

Conclusion

Francisca Wollerton's contributions to biotechnology through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for innovative treatments in the medical field.